Trial of Bevacizumab and Ixabepilone for Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT01057212 · TERMINATED
Trial details
- NCT number
- NCT01057212
- Sponsor
- Providence Health & Services
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2013-12-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.